320 related articles for article (PubMed ID: 19846950)
1. In vivo model of pseudomyxoma peritonei for novel candidate drug discovery.
Chua TC; Akther J; Yao P; Morris DL
Anticancer Res; 2009 Oct; 29(10):4051-5. PubMed ID: 19846950
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
[TBL] [Abstract][Full Text] [Related]
3. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
Murphy EM; Sexton R; Moran BJ
Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
[TBL] [Abstract][Full Text] [Related]
4. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
5. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
6. MUC2 is a molecular marker for pseudomyxoma peritonei.
O'Connell JT; Hacker CM; Barsky SH
Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
[TBL] [Abstract][Full Text] [Related]
7. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
8. Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype.
Flatmark K; Reed W; Halvorsen T; Sørensen O; Wiig JN; Larsen SG; Fodstad Ø; Giercksky KE
BMC Cancer; 2007 Jun; 7():116. PubMed ID: 17603904
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary metastases in pseudomyxoma peritonei syndrome.
Mortman KD; Sugarbaker PA; Shmookler BM; DeGuzman VC; Soberman MS
Ann Thorac Surg; 1997 Nov; 64(5):1434-6. PubMed ID: 9386716
[TBL] [Abstract][Full Text] [Related]
10. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.
Smeenk RM; van Velthuysen ML; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2008 Feb; 34(2):196-201. PubMed ID: 17524597
[TBL] [Abstract][Full Text] [Related]
11. Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.
Choudry HA; Mavanur A; O'Malley ME; Zeh HJ; Guo Z; Bartlett DL
Ann Surg Oncol; 2012 May; 19(5):1402-9. PubMed ID: 22302271
[TBL] [Abstract][Full Text] [Related]
12. The coexistence of low-grade mucinous neoplasms of the appendix and appendiceal diverticula: a possible role in the pathogenesis of pseudomyxoma peritonei.
Lamps LW; Gray GF; Dilday BR; Washington MK
Mod Pathol; 2000 May; 13(5):495-501. PubMed ID: 10824920
[TBL] [Abstract][Full Text] [Related]
13. Pseudomyxoma peritonei of appendiceal cancer with metastasis to the stomach: report of a case.
Yoshida R; Yoshioka K; Yoshitaka H; Kida H; Fukunaga S; Nakai K; Osawa T; Baden Y; Sakaida N
Surg Today; 2002; 32(6):547-50. PubMed ID: 12107784
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of pseudomyxoma peritonei is developing].
Lepistö A; Osterlund P; Järvinen HJ
Duodecim; 2010; 126(14):1693-9. PubMed ID: 20804088
[TBL] [Abstract][Full Text] [Related]
15. Pseudomyxoma peritonei syndrome of appendiceal origin: an overview.
Brueggen C; Baird G; Meisheid A
Clin J Oncol Nurs; 2007 Aug; 11(4):525-32. PubMed ID: 17723965
[TBL] [Abstract][Full Text] [Related]
16. [Ovarian mucinous adenocarcinoma, mucocele of the appendix and pseudomyxoma peritonei: case report with immunohistochemical analysis].
Singh A; Winkler M; Handt S; Rath W
Zentralbl Gynakol; 2000; 122(3):175-8. PubMed ID: 10756603
[TBL] [Abstract][Full Text] [Related]
17. Unusual tumors of the appendix and pseudomyxoma peritonei.
Carr NJ; Sobin LH
Semin Diagn Pathol; 1996 Nov; 13(4):314-25. PubMed ID: 8946609
[TBL] [Abstract][Full Text] [Related]
18. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.
Jess P; Iversen LH; Nielsen MB; Hansen F; Laurberg S; Rasmussen PC
Dis Colon Rectum; 2008 Jun; 51(6):868-74. PubMed ID: 18297361
[TBL] [Abstract][Full Text] [Related]
19. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.
Legué LM; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
Clin Colorectal Cancer; 2019 Mar; 18(1):1-7. PubMed ID: 30611664
[TBL] [Abstract][Full Text] [Related]
20. [Pseudomyxoma peritonei: new concept and new therapeutic approach].
Loungnarath R; Causeret S; Brigand C; Gilly FN; Glehen O
Ann Chir; 2005 Feb; 130(2):63-9. PubMed ID: 15737316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
